phenelzine has been researched along with perphenazine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Campbell, KN | 1 |
| Ailabouni, H; Sulman, FG; Zor, U | 1 |
| Chopra, YM; Dandiya, PC | 1 |
| Dandiya, PC; Patni, SK | 1 |
| Beck, AT; Morris, JB | 1 |
| Bhargava, LP; Dandiya, PC | 1 |
| Marriott, AS; Spencer, PS | 1 |
| Ban, TA; Lehmann, HE; Warnes, H | 1 |
| CHAMBERLAIN, A; CHAPPLE, ED; ESSER, AH; KLINE, NS | 1 |
| KURLAND, AA; MICHAUX, MH | 1 |
| CHAMBERLAIN, AS; CHAPPLE, ED; ESSER, AH; KLINE, NS | 1 |
| COOPER, TB; CRANSWICK, EH; SIMPSON, GM | 1 |
1 review(s) available for phenelzine and perphenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for phenelzine and perphenazine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Phenothiazine derivatives in urine: "false negative results" with the Forrest color test (FPN), and a method for their elimination.
Topics: Amitriptyline; Chlordiazepoxide; Chlorpromazine; Chlorprothixene; Humans; In Vitro Techniques; Indicators and Reagents; Iron; Nitrates; Perchlorates; Perphenazine; Phenelzine; Phenothiazines; Trifluoperazine; Urine | 1965 |
The combined effect of monoamine oxidase inhibitors and corticosteroids on the pituitary-gonadal system of male rats.
Topics: Adrenocorticotropic Hormone; Animals; Castration; Chorionic Gonadotropin; Dexamethasone; Growth Hormone; Hydrocortisone; Luteinizing Hormone; Male; Monoamine Oxidase Inhibitors; Organ Size; Perphenazine; Phenelzine; Pituitary Gland; Prostate; Rats; Seminal Vesicles; Thyrotropin | 1966 |
The mechanism of the potentiating effect of antidepressant drugs on the protective influenc oe of diphenhydramine in experimental catatonia. The role of histamine.
Topics: Animals; Antidepressive Agents; Brain; Brain Chemistry; Catatonia; Diphenhydramine; Drug Synergism; Histamine; Humans; Male; Monoamine Oxidase Inhibitors; Nortriptyline; Perphenazine; Phenelzine; Rats; Time Factors; Tryptamines | 1974 |
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibitors; Nortriptyline; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Rats; Tremorine | 1972 |
The efficacy of antidepressant drugs. A review of research (1958-1972).
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Depression; Dibenzazepines; Drug Evaluation; Female; Humans; Imipramine; Iprindole; Isocarboxazid; Lithium; Male; Middle Aged; Nialamide; Opipramol; Perphenazine; Phenelzine; Placebos; Research Design; Tranylcypromine; United States | 1974 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine Oxidase Inhibitors; Nialamide; Nicotine; Nortropanes; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Physostigmine; Rats; Scopolamine; Sulfonic Acids; Tolazoline; Tremor; Tremorine; Trihexyphenidyl; Tryptamines | 1968 |
Effects of centrally acting drugs on exploratory behaviour in rats.
Topics: Amobarbital; Amphetamine; Animals; Antidepressive Agents; Chlordiazepoxide; Chlorpromazine; Defecation; Exploratory Behavior; Haloperidol; Imipramine; Male; Meprobamate; Perphenazine; Phenelzine; Rats; Tranquilizing Agents; Tranylcypromine | 1965 |
Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases.
Topics: Adult; Chlorpromazine; Female; Humans; Imipramine; Intestinal Obstruction; Male; Mental Disorders; Methotrimeprazine; Middle Aged; Perphenazine; Phenelzine; Prochlorperazine; Thioridazine; Trifluoperazine | 1967 |
THE MEASUREMENT OF ACTIVITY PATTERNS OF SCHIZOPHRENIC PATIENTS.
Topics: Chlorpromazine; Humans; Imipramine; Perphenazine; Phenelzine; Placebos; Reserpine; Schizophrenia; Trifluoperazine | 1963 |
COMBINED PSYCHOTROPIC DRUG THERAPY.
Topics: Barbiturates; Chlorpromazine; Humans; Imipramine; Perphenazine; Phenelzine; Psychopharmacology; Psychotropic Drugs; Thioridazine; Trifluoperazine | 1963 |
PRODUCTIVITY OF CHRONIC SCHIZOPHRENICS IN A SHELTERED WORKSHOP: A QUANTITATIVE EVALUATION OF THE EFFECTS OF DRUG THERAPY.
Topics: Biomedical Research; Drug Therapy; Humans; Occupational Therapy; Perphenazine; Phenelzine; Placebos; Reserpine; Schizophrenia; Sheltered Workshops | 1965 |
TWO-YEAR FOLLOW-UP STUDY OF PROTEIN-BOUND IODINE ELEVATION IN PATIENTS RECEIVING PERPHENAZINE.
Topics: Biomedical Research; Drug Therapy; Follow-Up Studies; Iodine; Mental Disorders; Perphenazine; Phenelzine; Placebos; Reserpine; Schizophrenia; Statistics as Topic; Thyroid Function Tests | 1965 |